We are live on ! Find out more
CLCD

CoLucid Pharmaceuticals, Inc.
CLCD

Delisted

CLCD was delisted on the 28th of February, 2017.

Back to rankings

Fund managers haven’t disclosed any holdings of CLCD yet.

CLCD Hedge Fund Activity: Q2 2017 in Review

0 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in CoLucid Pharmaceuticals, Inc. (CLCD) for Q2 2017, worth a combined $0 — down 100% from $55K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CLCD and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was FNY Partners Fund, exiting entirely with an estimated $55K sold.

  • 0 institutional investors held CoLucid Pharmaceuticals, Inc. (CLCD) as of Q2 2017, down from 1 in Q1 2017.
  • Funds reported $0 of CoLucid Pharmaceuticals, Inc. stock for Q2 2017, down 100% quarter-over-quarter.
  • 0 funds opened new CoLucid Pharmaceuticals, Inc. positions in Q2 2017 and 1 closed out, a net change of -1 holder.
  • The largest CoLucid Pharmaceuticals, Inc. seller in Q2 2017 was FNY Partners Fund, an estimated $55K sold.

Based on aggregated 13F filings for Q2 2017.